Biphasic effects of ANP infusion in conscious, euvolumic rats: Roles of AQP2 and ENaC trafficking

American Journal of Physiology - Renal Physiology

Volumn 290, Issue 2, 2006, Pages

  Wang, Weidong ^a   Li, Chunling ^a,b   Nejsum, Lene N ^a   Li, Hongyan ^a   Soo, Wan Kim ^a   Kwon, Tae Hwan ^a,c   Jonassen, Thomas E N ^d   Knepper, Mark A ^e   Thomsen, Klaus ^b   Frøkiær, Jørgen ^a,b   Nielsen, Søren ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Kyungpook National University School of Medicine   (South Korea)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e Laboratory of Kidney and Electrolyte Metabolism NHBLI   (United States)

Author keywords

Aquaporin 2; Atrial natriuretic peptide; cGMP; Collecting duct; Diuresis; Epithelial sodium channel; Natriuresis; Servo controlled replacement

Indexed keywords

AQUAPORIN 2; ATRIAL NATRIURETIC FACTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; SODIUM CHANNEL; AQP2 PROTEIN, RAT; EPITHELIAL SODIUM CHANNEL; SODIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIURESIS; FEMALE; GENETIC TRANSFECTION; KIDNEY CLEARANCE; KIDNEY COLLECTING TUBULE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM URINE LEVEL; URINE FLOW RATE; ANIMAL; CELL LINE; DRUG EFFECT; ELECTROLYTE BALANCE; GENETICS; HUMAN; KIDNEY; METABOLISM; MICTURITION; PROTEIN TRANSPORT; TIME; URINE; WISTAR RAT;

ANIMALS; AQUAPORIN 2; ATRIAL NATRIURETIC FACTOR; CELL LINE; EPITHELIAL SODIUM CHANNEL; FEMALE; HUMANS; KIDNEY; PROTEIN TRANSPORT; RATS; RATS, WISTAR; SODIUM; SODIUM CHANNELS; TIME FACTORS; TRANSFECTION; URINATION; WATER-ELECTROLYTE BALANCE;

EID: 33644850608     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00070.2005     Document Type: Article

References (40)

1. Abraham WT, Hensen J, Kim JK, Durr J, Lesnefsky EJ, Groves BM, and Schrier RW. Atrial natriuretic peptide and urinary cyclic guanosine monophosphate in patients with chronic heart failure. J Am Soc Nephrol 2: 1697-1703, 1992.
2. Abu-Amarah I and Balment RJ. Vascular, renal, and endocrine responses to low-dose atrial natriuretic peptide in the fluid-balanced New Zealand genetically hypertensive rats with and without endogenous arginine vasopressin. Can J Physiol Pharmacol 77: 102-110, 1999.
3. Beutler KT, Masilamani S, Turban S, Nielsen J, Brooks HL, Ageloff S, Fenton RA, Packer RK, and Knepper MA. Long-term regulation of ENaC expression in kidney by angiotensin II. Hypertension 41: 1143-1150, 2003.
4. Bouley R, Breton S, Sun T, McLaughlin M, Nsumu NN, Lin HY, Ausiello DA, and Brown D. Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells. J Clin Invest 106: 1115-1126, 2000.
5. Bouley R, Pastor-Soler N, Cohen O, McLaughlin M, Breton S, and Brown D. Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra). Am J Physiol Renal Physiol 288: F1103-F1112, 2005.
6. Brenner BM, Ballermann BJ, Gunning ME, and Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 70: 665-699, 1990.
7. Burgess WJ and Balment RJ. The involvement of vasopressin in the renal actions of atrial natriuretic peptide in conscious fluid-balanced rats. J Endocrinol 138: 413-420, 1993.
8. Burgess WJ and Balment RJ. Plasma atrial natriuretic peptide in vasopressin deficiency: the effects of acute water deprivation in rats. J Endocrinol 135: 431-438, 1992.
9. Burnett JC Jr, Granger JP, and Opgenorth TJ. Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol Renal Fluid Electrolyte Physiol 247: F863-F866, 1984.
10. Campbell HT, Lightfoot BO, and Sklar AH. Four-hour atrial natriuretic peptide infusion in conscious rats: effects on urinary volume, sodium, and cyclic GMP. Proc Soc Exp Biol Med 189: 317-324, 1988.
11. Chartier L, Schiffrin E, Thibault G, and Garcia R. Atrial natriuretic factor inhibits the stimulation of aldosterone secretion by angiotensin II, ACTH and potassium in vitro and angiotensin II-induced steroidogenesis in vivo. Endocrinology 115: 2026-2028, 1984.
12. 2-receptor agonist/antagonist treatment. Am J Physiol Renal Physiol 278: F29-F42, 2000.
13. De Bold AJ, Borenstein HB, Veress AT, and Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28: 89-94, 1981.
14. Dillingham MA and Anderson RJ. Inhibition of vasopressin action by atrial natriuretic factor. Science 231: 1572-1573, 1986.
15. Garcia R, Cantin M, Genest J, Gutkowska J, and Thibault G. Body fluids and plasma atrial peptide after its chronic infusion in hypertensive rats. Proc Soc Exp Biol Med 185: 352-358, 1987.
16. Granger JP, Opgenorth TJ, Salazar J, Romero JC, and Burnett JC Jr. Long-term hypotensive and renal effects of atrial natriuretic peptide. Hypertension 8: II112-II116, 1986.
17. Hager H, Kwon TH, Vinnikova AK, Masilamani S, Brooks HL, Frøkiær J, Knepper MA, and Nielsen S. Immunocytochemical and immunoelectron microscopic localization of α-, β-, and γ-ENaC in rat kidney. Am J Physiol Renal Physiol 280: F1093-F1106, 2001.
18. Huang CL, Ives HE, and Cogan MG. In vivo evidence that cGMP is the second messenger for atrial natriuretic factor. Proc Natl Acad Sci USA 83: 8015-8018, 1986.
19. 1 epithelial cells. Proc Natl Acad Sci USA 92: 7212-7216, 1995.
20. + channels in A6 cells. Am J Physiol Renal Fluid Electrolyte Physiol 266: F506-F511, 1994.
21. Light DB, Schwiebert EM, Karlson KH, and Stanton BA. Atrial natriuretic peptide inhibits a cation channel in renal inner medullary collecting duct cells. Science 243: 383-385, 1989.
22. Loffing J, Zecevic M, Feraille E, Kaissling B, Asher C, Rossier BC, Firestone GL, Pearce D, and Verrey F. Aldosterone induces rapid apical translocation of ENaC in early portion of renal collecting system: possible role of SGK. Am J Physiol Renal Physiol 280: F675-F682, 2001.
23. Masilamani S, Kim GH, Mitchell C, Wade JB, and Knepper MA. Aldosterone-mediated regulation of ENaC α, β, and γ subunit proteins in rat kidney. J Clin Invest 104: R19-R23, 1999.
24. Nielsen S, Chou CL, Marples D, Christensen EI, Kishore BK, and Knepper MA. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci USA 92: 1013-1017, 1995.
25. Nielsen S, Frøkiær J, Marples D, Kwon TH, Agre P, and Knepper MA. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82: 205-244, 2002.
26. Nonoguchi H, Knepper MA, and Manganiello VC. Effects of atrial natriuretic factor on cyclic guanosine monophosphate and cyclic adenosine monophosphate accumulation in microdissected nephron segments from rats. J Clin Invest 79: 500-507, 1987.
27. Nonoguchi H, Sands JM, and Knepper MA. Atrial natriuretic factor inhibits vasopressin-stimulated osmotic water permeability in rat inner medullary collecting duct. J Clin Invest 82: 1383-1390, 1988.
28. Nonoguchi H, Sands JM, and Knepper MA. ANF inhibits NaCl and fluid absorption in cortical collecting duct of rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 256: F179-F186, 1989.
29. Reif MC, Troutman SL, and Schafer JA. Sodium transport by rat cortical collecting tubule. Effects of vasopressin and desoxycorticosterone. J Clin Invest 77: 1291-1298, 1986.
30. + transport in isolated rat CCD: effects of bradykinin, ANP, clonidine, and hydrochlorothiazide. Am J Physiol Renal Fluid Electrolyte Physiol 260: F86-F95, 1991.
31. Sands JM, Nonoguchi H, and Knepper MA. Hormone effects on NaCl permeability of rat inner medullary collecting duct. Am J Physiol Renal Fluid Electrolyte Physiol 255: F421-F428, 1988.
32. Schlatter E, Cermak R, Forssmann WG, Hirsch JR, Kleta R, Kuhn M, Sun D, and Schafer JA. cGMP-activating peptides do not regulate electrogenic electrolyte transport in principal cells of rat CCD. Am J Physiol Renal Fluid Electrolyte Physiol 271: F1158-F1165, 1996.
33. Shenker Y, Sider RS, Ostafin EA, and Grekin RJ. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. J Clin Invest 76: 1684-1687, 1985.
34. Stanton BA. Characterization of apical and basolateral membrane conductances of rat inner medullary collecting duct. Am J Physiol Renal Fluid Electrolyte Physiol 256: F862-F868, 1989.
35. Stanton BA. Molecular mechanisms of ANP inhibition of renal sodium transport. Can J Physiol Pharmacol 69: 1546-1552, 1991.
36. Takeda S, Kusano E, Murayama N, Asano Y, Hosoda S, Sokabe H, and Kawashima H. Atrial natriuretic peptide elevates cGMP contents in glomeruli and in distal tubules of rat kidney. Biochem Biophys Res Commun 136: 947-954, 1986.
37. Terada Y, Moriyama T, Martin BM, Knepper MA, and Garcia-Perez A. RT-PCR microlocalization of mRNA for guanylyl cyclase-coupled ANF receptor in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 261: F1080-F1087, 1991.
38. Tomita K, Pisano JJ, and Knepper MA. Control of sodium and potassium transport in the cortical collecting duct of the rat. Effects of bradykinin, vasopressin, and deoxycorticosterone. J Clin Invest 76: 132-136, 1985.
39. Waldhausl W, Vierhapper H, and Nowotny P. Prolonged administration of human atrial natriuretic peptide in healthy men: evanescent effects on diuresis and natriuresis. J Clin Endocrinol Metab 62: 956-959, 1986.
40. Walker LA, Buscemi-Bergin M, and Gellai M. Renal hemodynamics in conscious rats: effects of anesthesia, surgery, and recovery. Am J Physiol Renal Fluid Electrolyte Physiol 245: F67-F74, 1983.